Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q, Sun L, Luo B, Shang L, Chen W, Bai Y, Tang M, He M, Wu L, Ma Q, Hou D, He J.
Xiao S, et al. Among authors: hou d.
Age Ageing. 2017 Sep 1;46(5):767-773. doi: 10.1093/ageing/afx045.
Age Ageing. 2017.
PMID: 28419192
Clinical Trial.